Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:16 AM
Ignite Modification Date:
2025-12-25 @ 12:16 AM
NCT ID:
NCT00870558
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Diagnosis of hepatocellular carcinoma (HCC)
* Alpha-fetoprotein \< 20 ng/mL
* Must have undergone curative treatment for HCC within the past 8-20 weeks, including 1 of the following:
* Curative resection
* Alcohol ablation, radiofrequency ablation, or cryotherapy (for 1 or 2 nodules \< 5 cm in diameter)
* No ascites
* No other intrahepatic involvement or nodule progression as assessed by ultrasound
* No extrahepatic metastases
PATIENT CHARACTERISTICS:
* WHO performance status 0-2
* ANC ≥ 1,500/mm³
* Platelet count ≥ 50,000/mm³
* Bilirubin ≤ 51 μmol/L
* Creatinine ≤ 120 μmol/L
* Not pregnant or nursing
* Negative pregnancy test
* Child-Pugh score \< 8 (class B)
* No decompensated cirrhosis
* No encephalopathy
* No uncontrolled bleeding
* No portal thrombosis, right- or left-branch thrombosis, extrahepatic thrombosis, or portal reflux by doppler or CT scan
* No unstable medical or surgical disease
* No contraindication to vascular arteriography
* No history of complications after injection of iodine contrast agents
* Not incarcerated
PRIOR CONCURRENT THERAPY:
* See Disease Characteristics
* Recovered from all prior therapy
* No prior hormonal treatment, including tamoxifen and somatostatin analogs
* No prior systemic chemotherapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00870558
Study Brief:
Protocol Section:
NCT00870558